#
info@crystallizationsummit.com
English
English
Bangla
French
Spanish
Arabic
Office Address
info@crystallizationsummit.com
Phone: +1 732-978-0828
Pinterest
Social List
Home
About
Purpose
Typical Attendees
Organizer
Programs
2024
Program Schedule
Venue
2024 Speakers
Sponsors
Organizing Committee
2023
Program Schedule
Sponsors
2022
2022 Report
Program
2021
2021 Report
2020
2020 Report
Registration
2024 Registration
Courtesy Cancelation
Sponsors
2024
2023
2022
News Right Sidebar
Home
News Right Sidebar
pcs2021-abstracts ,
pcs2021-speakers ,
pcs2021 ,
session-1-smarter-solid-form-pre-formulation-studies
Understanding and Controlling the API Form/Powder Property Risks in Drug Substance and Product Processes
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-1-smarter-solid-form-pre-formulation-studies
Absolute Structure Determination of API Molecules by MicroED analysis of Cocrystals formed based on Cocrystal Propensity Prediction Calculations
June 16, 2020
wpadm
pcs2020-abstracts ,
pcs2020 ,
session-1-smarter-solid-state-research-by-prediction-and-simulation
Locality, Strength, and Hierarchy of Intermolecular Interactions in Crystallization
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-2-particle-engineering-ds-dp-co-processing
Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-2-particle-engineering-ds-dp-co-processing
Crystal Habit Modifications and Spherical Crystallization Design in Solution
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-2-particle-engineering-ds-dp-co-processing
Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-2-particle-engineering-ds-dp-co-processing
Bridging the Gap between Drug Substance and Drug Product Processing via Co-Processing
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-3-physical-property-based-crystallization-process-development
The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-3-physical-property-based-crystallization-process-development
Continuous Crystallization and Purification: The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes
June 16, 2020
wpadm
pcs2021-abstracts ,
pcs2021 ,
session-3-physical-property-based-crystallization-process-development
Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process
June 16, 2020
wpadm
1
2
3
…
8
9
10
11
12
